Gene Therapy for Congenital Hearing Loss

Alisa Timashpolsky, Stephen R. Chorney, Robert C. O’Reilly

Research output: Contribution to journalReview articlepeer-review

Abstract

Purpose of Review: This review provides the otolaryngology community with background on the basics of gene therapy for congenital hearing loss along with potential frontiers in this field. Recent Findings: In the last several years, there has been a tremendous increase in the amount of basic science research in gene therapy models for sensorineural hearing loss. Most work has been limited to murine models, but the transition to nonhuman primates has also occurred. There are still concerns with identifying the proper viral capsids, developing the most effective delivery approach, and timing the injection in humans to adequately restore hearing capability. Summary: Despite a growing interest and rapid advancement of the gene therapy research, there are still several challenges that remain before this can be utilized for children with congenital hearing loss.

Original languageEnglish (US)
JournalCurrent Otorhinolaryngology Reports
DOIs
StateAccepted/In press - 2022

Keywords

  • Adeno-associated virus
  • Congenital hearing loss
  • Gene therapy

ASJC Scopus subject areas

  • Surgery
  • Immunology and Allergy
  • Otorhinolaryngology
  • Clinical Neurology

Fingerprint

Dive into the research topics of 'Gene Therapy for Congenital Hearing Loss'. Together they form a unique fingerprint.

Cite this